Bionano Genomics (BNGO) Revenue (2017 - 2026)

Bionano Genomics has disclosed Revenue across 10 years of filings, most recently posting $6.7 million for Q1 2026.

• Revenue for Q1 2026 came in at $6.7 million, up 3.56% year-over-year; the trailing twelve-month figure through Mar 2026 was $28.7 million (up 0.96% YoY), and the FY2025 annual result was $28.5 million, down 7.37% from the prior year.
• Revenue came in at $6.7 million for Q1 2026 at Bionano Genomics, down from $8.0 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $10.7 million in Q4 2023 to a low of $5.7 million in Q1 2022.
• The 5-year median for Revenue is $7.4 million (2023), against an average of $7.6 million.
• Across the five-year window, Revenue surged 79.8% in 2022 and tumbled 34.83% in 2024, its largest moves.
• Bionano Genomics' Revenue stood at $8.2 million in 2022, then jumped by 30.51% to $10.7 million in 2023, then decreased by 23.86% to $8.2 million in 2024, then retreated by 2.6% to $8.0 million in 2025, then fell by 15.9% to $6.7 million in 2026.
• The last three Revenue figures came in at $6.7 million (Q1 2026), $8.0 million (Q4 2025), and $7.4 million (Q3 2025), per Business Quant data.